Related Experiment Video
Updated: Sep 9, 2025
Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
Published on: January 20, 2014
Cumulative motor index in spinal muscular atrophy after gene therapy: baseline predicts maximal recovery
Rémi Barrois1, Christine Barnerias2, Anaïs Hervé3
1Clinical Neurophysiology Department, AP-HP, Hôpital Necker Enfants Malades, Paris, France; Centre Borelli - UMR 9010 Centre Borelli, Gif-sur-Yvette, France; Paris Cité University, Paris, France.
Objective:
Higher compound muscle action potentials (CMAP) amplitudes are associated with motor milestones acquisitions in patients with symptomatic early onset spinal muscular atrophy (SMA) after gene therapy (GT). This study aimed to propose a predictive model for the evolution of CMAP amplitudes over 36 months in these patients.
Methods:
Nineteen SMA patients (mean age 8.5 months; 12 with two SMN2 copies, 7 with three) were prospectively assessed for motor scores and CMAP amplitudes (median, ulnar, fibular, tibial nerves). A cumulative motor index (CMI, sum of CMAP amplitudes) was calculated.
Results:
Post-GT, CMAP amplitudes and CMI increased significantly (p < 0.05) but plateaued at low pathological values after 24 months. The plateau occurred earlier and peaked lower in patients with two SMN2 copies, correlating also with a clinical motor plateau. In these patients, baseline CMI strongly predicted the maximal plateau value at 36 months (CMIM36=2.67×CMIM0+1.92; R2 = 0.97). Patients with three SMN2 copies plateaued at ∼10 mV, regardless of baseline CMI (R2 = 0.70).
Conclusion:
The baseline CMI value emerged as a strong predictor of its maximal value after GT, along with the number of copies of SMN2.
Significance:
These results support the validation of CMI as a guide for optimal patient selection and therapeutic management.
More Related Videos
05:55Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
Published on: October 3, 2011
10:57Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
Published on: July 13, 2015
